BBIBP-CorV (Sinopharm)

About Us
- Get to know Avivir
  
  Innovation and investment in pharmaceuticals
  
  The "Avivir" group of companies is a research, production, and investment organization engaged in the development of advanced medical devices, technologies, and innovative pharmaceutical products.
- Partners and clients
  
  Collaborating with leading companies
  
  Our clients and partners are industry leaders and innovative startups.
Services
- Medical Institution Equipment
  
  At our company, we offer complete equipment solutions for healthcare institutions, tackling the most complex demands in the sector. We collaborate with top global manufacturers, procuring a diverse array of equipment essential for diagnostics, treatment, and surgical procedures.
- Medical Device Registration
  
  Offering comprehensive, professional, and expedited support for medical device registration.
Products
- Diagnostic tests
  
  Diagnostic tests
  
  Covid-19 tests
  Syphilis diagnostic tests
  Hepatitis diagnostic tests
- Medical equipment
  
  Everything for equipping institutions
  
  Obstetrics and Gynecology
  Anesthesiology and Resuscitation
  Gastroenterology
  Traumatology and Orthopedics
  Dentistry and Dental Prosthetics
  All equipment
- Parapharmaceuticals
  
  Parapharmaceuticals
  
  We offer the opportunity to 'engineer' sought-after dietary supplements from high-quality and safe raw materials - recipes that meet the demands of consumers and adhere to the latest health and wellness trends.
Contacts

About Us
- Get to know Avivir
  
  Innovation and investment in pharmaceuticals
  
  The "Avivir" group of companies is a research, production, and investment organization engaged in the development of advanced medical devices, technologies, and innovative pharmaceutical products.
- Partners and clients
  
  Collaborating with leading companies
  
  Our clients and partners are industry leaders and innovative startups.
Services
- Medical Institution Equipment
  
  At our company, we offer complete equipment solutions for healthcare institutions, tackling the most complex demands in the sector. We collaborate with top global manufacturers, procuring a diverse array of equipment essential for diagnostics, treatment, and surgical procedures.
- Medical Device Registration
  
  Offering comprehensive, professional, and expedited support for medical device registration.
Products
- Diagnostic tests
  
  Diagnostic tests
  
  Covid-19 tests
  Syphilis diagnostic tests
  Hepatitis diagnostic tests
- Medical equipment
  
  Everything for equipping institutions
  
  Obstetrics and Gynecology
  Anesthesiology and Resuscitation
  Gastroenterology
  Traumatology and Orthopedics
  Dentistry and Dental Prosthetics
  All equipment
- Parapharmaceuticals
  
  Parapharmaceuticals
  
  We offer the opportunity to 'engineer' sought-after dietary supplements from high-quality and safe raw materials - recipes that meet the demands of consumers and adhere to the latest health and wellness trends.
Contacts

BBIBP-CorV (Sinopharm)

BBIBP-CorV, developed by Sinopharm, is one of two whole-virion inactive vaccines against COVID-19. It is a two-dose vaccine for intramuscular injection with a 3-4 week interval between doses. Stored between 2-8 °C.

Sinopharm

BBIBP-CorV, an inactive beta-propiolactone whole-virion virus, underwent Phase III trials in China, the UAE and Bahrain. At the end of December, Sinopharm announced that the drug’s effectiveness reached 79%, though a detailed report on the trial’s results has yet to be published

Vaccine

BBIBP-CorV (Sinopharm)

Developer

Sinopharm, China

Producer

Sinopharm, China

Status

On December 31, 2020, the National Health Commission of the People’s Republic of China approved BBIBP-CorV for widespread use as the first domestically produced coronavirus vaccine. This approval was issued the day after Sinopharm announced that the vaccine had shown 79.34% effectiveness in an intermediate analysis of Phase III clinical trials.

Key information

What’s in the vaccine?

One of two whole-virion inactive vaccines against COVID-19, developed by Sinopharm. It is a two-dose vaccine for intramuscular injection with a 3-4 week interval between doses. Stored between 2-8 °C.